The purpose of this study is to characterise the metabolism, excretion and pharmacokinetics of a single oral dose of \[14C\] AZD1236 in healthy male subjects.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
4
Oral solution 1mg/mL
Research Site
Macclesfield, CHESHIRE, United Kingdom
Pharmacokinetic profile. Concentration of AZD1236 in plasma
Time frame: Before and after dosing
Total Radioactivity
Time frame: Before and after dosing
Adverse events, clinical chemistry, haematology, urinalysis, pulse and blood pressure, ECG and physical examination
Time frame: Before and after dosing
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.